(BCR) C.R. Bard – Bull of the Day

September 4th, 2009

C.R. Bard (BCR) operates in vascular, urology, oncology and surgical specialty markets. These end-markets should remain insulated from the current economic turmoil.

Many of the company’s products are used in interventional medicine — life-saving surgical procedures. Future quarters will be met with a headwind from foreign exchange.

However, with less than a third of sales outside of the United States, the impact will be less than that for BCR’s competitors.

We retain our Outperform rating on the shares.

Zacks Investment Research
View original at: Zacks.com News Feed

More on this topic (What's this?)
C.R. Bard Raises Dividend (Crossing Wall Street, 6/10/11)
CR Bard Reports Mixed Earnings (BCR) (Benzinga, 10/21/10)
Morgan Keegan Raises C.R. Bard Price Target (Benzinga, 10/22/10)
C.R Bard Posts Lower Profit (Benzinga, 10/22/10)
Read more on C.R. Bard at Wikinvest

Related Posts:

  1. (ISRG) Intuitive Surgical- Is the Bull of the DayIntuitive Surgical’s (ISRG) story is improving. A new product was developed as an upgrade to...


Search Posts by Tag: | | Healthcare | Medical Instruments & Supplies

RSS Feeds by Tag: BCR | Cr Bard Inc | Healthcare | Medical Instruments & Supplies |

Other Posts by: | RSS Feed for this author